Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie A Barta

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Chest|January 10, 2022
Variation in Adherence to Lung Cancer Screening Among Vulnerable PopulationsJulie A Barta
The Lancet. Respiratory Medicine|February 17, 2025
Use of lung-cancer trends for global and public health prioritiesEunji Choi, Julie A Barta
Molecular Cancer Research : MCR|September 19, 2018
Lung-Enriched Mutations in the p53 Tumor Suppressor: A Paradigm for Tissue-Specific Gain of Oncogenic FunctionJulie A Barta, Steven B McMahon
Clinics in Geriatric Medicine|October 10, 2017
Lung Cancer in the Older PatientJulie A Barta, Ralph G Zinner, Michael Unger
Annals of Global Health|February 12, 2019
Global Epidemiology of Lung CancerJulie A Barta, Charles A Powell, Juan P Wisnivesky
Chest|September 11, 2024
Multi-Cancer and Single-Cancer Early Detection Testing: Opportunities and ChallengesJulie A Barta, Peter J Mazzone, Viswam S Nair
The American Journal of the Medical Sciences|April 26, 2022
Molecular lung cancer: How targeted therapies and personalized medicine are re-defining cancer careZachary L Quinn, Julie A Barta, Jennifer M Johnson
Journal of the American College of Radiology : JACR|December 3, 2025
Beyond Early Detection-Reframing Radiology's Role in Lung Cancer CareLisa Carter-Bawa, Ashley E Prosper, Julie A Barta
Carcinogenesis|May 9, 2019
The lung-enriched p53 mutants V157F and R158L/P regulate a gain of function transcriptome in lung cancerJulie A Barta, Kristen Pauley, Andrew V Kossenkov, et al.
Population Health Management|May 15, 2024
Implementation of High-Quality Lung Cancer Screening: Impact of Centralized vs. Decentralized ProcessesJacob F Martin, Gregory C Kane, Christine S Shusted, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Chest|January 10, 2022
Variation in Adherence to Lung Cancer Screening Among Vulnerable PopulationsJulie A Barta
The Lancet. Respiratory Medicine|February 17, 2025
Use of lung-cancer trends for global and public health prioritiesEunji Choi, Julie A Barta
Molecular Cancer Research : MCR|September 19, 2018
Lung-Enriched Mutations in the p53 Tumor Suppressor: A Paradigm for Tissue-Specific Gain of Oncogenic FunctionJulie A Barta, Steven B McMahon
Clinics in Geriatric Medicine|October 10, 2017
Lung Cancer in the Older PatientJulie A Barta, Ralph G Zinner, Michael Unger
Annals of Global Health|February 12, 2019
Global Epidemiology of Lung CancerJulie A Barta, Charles A Powell, Juan P Wisnivesky
Chest|September 11, 2024
Multi-Cancer and Single-Cancer Early Detection Testing: Opportunities and ChallengesJulie A Barta, Peter J Mazzone, Viswam S Nair
The American Journal of the Medical Sciences|April 26, 2022
Molecular lung cancer: How targeted therapies and personalized medicine are re-defining cancer careZachary L Quinn, Julie A Barta, Jennifer M Johnson
Journal of the American College of Radiology : JACR|December 3, 2025
Beyond Early Detection-Reframing Radiology's Role in Lung Cancer CareLisa Carter-Bawa, Ashley E Prosper, Julie A Barta
Carcinogenesis|May 9, 2019
The lung-enriched p53 mutants V157F and R158L/P regulate a gain of function transcriptome in lung cancerJulie A Barta, Kristen Pauley, Andrew V Kossenkov, et al.
Population Health Management|May 15, 2024
Implementation of High-Quality Lung Cancer Screening: Impact of Centralized vs. Decentralized ProcessesJacob F Martin, Gregory C Kane, Christine S Shusted, et al.
Pageof 5